- Home
- ITRM vs FMST Comparison
ITRM vs FMST Comparison
Compare ITRM & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- FMST
- Stock Information
- Founded
- ITRM 2015
- FMST 2005
- Country
- ITRM Ireland
- FMST Canada
- Employees
- ITRM N/A
- FMST N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- ITRM Health Care
- FMST Basic Materials
- Exchange
- ITRM Nasdaq
- FMST Nasdaq
- Market Cap
- ITRM 40.0M
- FMST 38.2M
- IPO Year
- ITRM 2018
- FMST N/A
- Fundamental
- Price
- ITRM $0.68
- FMST $2.92
- Analyst Decision
- ITRM Strong Buy
- FMST
- Analyst Count
- ITRM 2
- FMST 0
- Target Price
- ITRM $7.00
- FMST N/A
- AVG Volume (30 Days)
- ITRM 749.8K
- FMST 441.0K
- Earning Date
- ITRM 11-13-2025
- FMST 08-13-2025
- Dividend Yield
- ITRM N/A
- FMST N/A
- EPS Growth
- ITRM N/A
- FMST N/A
- EPS
- ITRM N/A
- FMST N/A
- Revenue
- ITRM N/A
- FMST N/A
- Revenue This Year
- ITRM N/A
- FMST N/A
- Revenue Next Year
- ITRM $249.35
- FMST N/A
- P/E Ratio
- ITRM N/A
- FMST N/A
- Revenue Growth
- ITRM N/A
- FMST N/A
- 52 Week Low
- ITRM $0.61
- FMST $0.55
- 52 Week High
- ITRM $3.02
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- ITRM 43.17
- FMST 47.43
- Support Level
- ITRM $0.61
- FMST $2.96
- Resistance Level
- ITRM $0.76
- FMST $3.24
- Average True Range (ATR)
- ITRM 0.05
- FMST 0.25
- MACD
- ITRM 0.01
- FMST -0.03
- Stochastic Oscillator
- ITRM 49.65
- FMST 14.12
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.